Ling YH - Search Results

1

Double blockade of cell cycle at g(1)-s transition and m phase by 3-iodoacetamido benzoyl ethyl ester, a new type of tubulin ligand.

Jiang JD, Denner L, Ling YH, Li JN, Davis A, Wang Y, Li Y, Roboz J, Wang LG, Perez-Soler R, Marcelli M, Bekesi G, Holland JF. Jiang JD, et al. Among authors: ling yh. Cancer Res. 2002 Nov 1;62(21):6080-8. Cancer Res. 2002. PMID: 12414632

2

Mechanisms of proteasome inhibitor PS-341-induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell lines.

Ling YH, Liebes L, Jiang JD, Holland JF, Elliott PJ, Adams J, Muggia FM, Perez-Soler R. Ling YH, et al. Clin Cancer Res. 2003 Mar;9(3):1145-54. Clin Cancer Res. 2003. PMID: 12631620

3

3-(Iodoacetamido)-benzoylurea: a novel cancericidal tubulin ligand that inhibits microtubule polymerization, phosphorylates bcl-2, and induces apoptosis in tumor cells.

Jiang JD, Davis AS, Middleton K, Ling YH, Perez-Soler R, Holland JF, Bekesi JG. Jiang JD, et al. Among authors: ling yh. Cancer Res. 1998 Dec 1;58(23):5389-95. Cancer Res. 1998. PMID: 9850070

4

3-m-bromoacetylamino benzoic acid ethyl ester: a new cancericidal agent that activates the apoptotic pathway through caspase-9.

Schlesinger M, Jiang JD, Roboz JP, Denner L, Ling YH, Holland JF, Bekesi JG. Schlesinger M, et al. Among authors: ling yh. Biochem Pharmacol. 2000 Dec 1;60(11):1693-702. doi: 10.1016/s0006-2952(00)00484-6. Biochem Pharmacol. 2000. PMID: 11077052

5

The phosphatase inhibitor menadione (vitamin K3) protects cells from EGFR inhibition by erlotinib and cetuximab.

Perez-Soler R, Zou Y, Li T, Ling YH. Perez-Soler R, et al. Among authors: ling yh. Clin Cancer Res. 2011 Nov 1;17(21):6766-77. doi: 10.1158/1078-0432.CCR-11-0545. Epub 2011 Sep 13. Clin Cancer Res. 2011. Retraction in: Clin Cancer Res. 2013 Sep 1;19(17):4901. doi: 10.1158/1078-0432.CCR-13-1912 PMID: 21914790 Retracted.

6

Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines.

Ling YH, Jiang JD, Holland JF, Perez-Soler R. Ling YH, et al. Mol Pharmacol. 2002 Sep;62(3):529-38. doi: 10.1124/mol.62.3.529. Mol Pharmacol. 2002. PMID: 12181429

7

PS-341, a novel proteasome inhibitor, induces Bcl-2 phosphorylation and cleavage in association with G2-M phase arrest and apoptosis.

Ling YH, Liebes L, Ng B, Buckley M, Elliott PJ, Adams J, Jiang JD, Muggia FM, Perez-Soler R. Ling YH, et al. Mol Cancer Ther. 2002 Aug;1(10):841-9. Mol Cancer Ther. 2002. PMID: 12492117

8

Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to Bortezomib, a novel proteasome inhibitor, in human H460 non-small cell lung cancer cells.

Ling YH, Liebes L, Zou Y, Perez-Soler R. Ling YH, et al. J Biol Chem. 2003 Sep 5;278(36):33714-23. doi: 10.1074/jbc.M302559200. Epub 2003 Jun 23. J Biol Chem. 2003. PMID: 12821677 Free article.

9

Enhanced sensitivity to the HER1/epidermal growth factor receptor tyrosine kinase inhibitor erlotinib hydrochloride in chemotherapy-resistant tumor cell lines.

Dai Q, Ling YH, Lia M, Zou YY, Kroog G, Iwata KK, Perez-Soler R. Dai Q, et al. Among authors: ling yh. Clin Cancer Res. 2005 Feb 15;11(4):1572-8. doi: 10.1158/1078-0432.CCR-04-0993. Clin Cancer Res. 2005. PMID: 15746062

10

Schedule-dependent cytotoxic synergism of pemetrexed and erlotinib in human non-small cell lung cancer cells.

Li T, Ling YH, Goldman ID, Perez-Soler R. Li T, et al. Among authors: ling yh. Clin Cancer Res. 2007 Jun 1;13(11):3413-22. doi: 10.1158/1078-0432.CCR-06-2923. Clin Cancer Res. 2007. PMID: 17545550

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

196 results

Search Page

Filters